383 related articles for article (PubMed ID: 17599812)
1. Relative contribution of peripheral versus central opioid receptors to antinociception.
Labuz D; Mousa SA; Schäfer M; Stein C; Machelska H
Brain Res; 2007 Jul; 1160():30-8. PubMed ID: 17599812
[TBL] [Abstract][Full Text] [Related]
2. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
3. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
[TBL] [Abstract][Full Text] [Related]
4. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
6. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
[TBL] [Abstract][Full Text] [Related]
7. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
8. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
[TBL] [Abstract][Full Text] [Related]
9. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
10. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.
Hiramatsu M; Inoue K; Ambo A; Sasaki Y; Kameyama T
Br J Pharmacol; 2001 Apr; 132(8):1948-56. PubMed ID: 11309268
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
Shannon HE; Lutz EA
Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
[TBL] [Abstract][Full Text] [Related]
13. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
14. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
Narita M; Takahashi Y; Takamori K; Funada M; Suzuki T; Misawa M; Nagase H
Jpn J Pharmacol; 1993 May; 62(1):15-24. PubMed ID: 8393497
[TBL] [Abstract][Full Text] [Related]
15. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
Ko MC; Johnson MD; Butelman ER; Willmont KJ; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1999 Dec; 291(3):1113-20. PubMed ID: 10565831
[TBL] [Abstract][Full Text] [Related]
16. Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors.
Shinoda K; Hruby VJ; Porreca F
Neurosci Lett; 2007 Jan; 411(2):143-6. PubMed ID: 17110034
[TBL] [Abstract][Full Text] [Related]
17. Methadone antinociception is dependent on peripheral opioid receptors.
He L; Kim J; Ou C; McFadden W; van Rijn RM; Whistler JL
J Pain; 2009 Apr; 10(4):369-79. PubMed ID: 19327642
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers.
Pruhs RJ; Peña RT; Quock RM
Life Sci; 2007 Apr; 80(19):1816-20. PubMed ID: 17379253
[TBL] [Abstract][Full Text] [Related]
19. Involvement of opioid receptors in the CGRP-induced antinociception in the nucleus accumbens of rats.
Li L; Wang X; Yu LC
Brain Res; 2010 Sep; 1353():53-9. PubMed ID: 20659434
[TBL] [Abstract][Full Text] [Related]
20. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
Suh HW; Chung KM; Kim YH; Huh SO; Song DK
Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]